Search Results
174 176 J.S. Lopez-Gonzalez, H. Prado-Garcia, D. Aguilar-Cazares, J.A. Molina-Guarneros, J. Morales-Fuentes, J.J. Mandoki, Lung Cancer 43 (2004) 275
prognostic indicator in patients with lung cancer Respiration 71 170 3 . 20. D Buergy
. PC Chen XM Zhou QX Chen 2008 Sleeve resection for lung cancer: a report of 82 cases
-validation of COPD biomarkers in a single step. Electrophoresis 2007; 28: 4401–4406. 11 Indovina P, Marcelli E, Maranta P, et al. Lung cancer proteomics: recent advances in biomarker
-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat. Oncol., 2006, 1, 30. 13 Habermehl, D., Herfarth, K. K., Bermejo, J. L., et al.: Single
References 1 Moldvay J, Rokszin G, Abonyi-Tóth Z, et al. Lung cancer drug therapy in Hungary – 3-year experience. Onco Targets Ther. 2015; 8: 1031
oncology. [A PET/CT és szerepe az onkológiában.] Orv Tud Ért. 2007; 80: 96–105. [Hungarian] 4 Shim SS, Lee KS, Kim BT, et al. Non-small cell lung cancer: prospective comparison of
. 27 Helissey C, Champiat S, Soria JC. Immune checkpoint inhibitors in advanced nonsmall cell lung cancer. Curr Opin Oncol. 2015; 27: 108–117. 28 Wu K, House L, Liu W
–1406. [Hungarian] 12 Bollineni, V. R., Koole, M. J., Pruim, J., et al.: Dynamics of tumor hypoxia assessed by 18 F-FAZA PET/CT in head and neck and lung cancer patients
obstructive pulmonary disease and lung cancer in Chinese. PLoS One 7, e46071 (2012) Lu J. Functional polymorphisms of CHRNA3 predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese PLoS One